The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors
- 1 October 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 129 (3) , 367-370
- https://doi.org/10.1016/0014-2999(86)90449-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesionsLife Sciences, 1985
- 5-Hydroxytryptamine can antagonize the ability of metoclopramide and SCH 23390 to enhance electrical field stimulation-evoked contractions of guinea-pig isolated stomach muscleJournal of Pharmacy and Pharmacology, 1985
- 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainEuropean Journal of Pharmacology, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH-23390, A POTENTIAL BENZAZEPINE ANTI-PSYCHOTIC WITH UNIQUE INTERACTIONS ON DOPAMINERGIC SYSTEMS1983
- [H-3]-LABELED KETANSERIN (R 41 468), A SELECTIVE H-3-LABELED LIGAND FOR SEROTONIN-2 RECEPTOR-BINDING SITES - BINDING-PROPERTIES, BRAIN DISTRIBUTION, AND FUNCTIONAL-ROLE1982
- Correlations between different measures of antiserotonin activity of drugsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- In vivo [3H]spiperone binding to the rat hippocampal formation: Involvement of dopamine receptorsEuropean Journal of Pharmacology, 1980